ORBIMED ADVISORS LLC

Holdings History for Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN)

Symbol: TERN on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned: 4,240,068 shares
Security Ownership %: 4.8%

Shares, Excluding Options vs Price

Value, Excluding Options

ORBIMED ADVISORS LLC ownership in Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (TERN)

05 Nov 2025 - ORBIMED ADVISORS LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,240,068 shares of Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (TERN). This represents 4.8% ownership of the company. This is the first filing by ORBIMED ADVISORS LLC disclosing ownership of Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (TERN).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
ORBIMED ADVISORS LLC	4.8%		$31,842,911	4,240,068			$7.51	13D/A	03 Nov 2025	05 Nov 2025, 16:13

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	1.9%	-4.7%	$86,993,320	2,153,300	-5,409,671	-72%	$40.40	Q4 2025
30 Sep 2025	1.4%	0%	$56,797,912	7,562,971	0		$7.51	Q3 2025
30 Jun 2025	0.71%	0%	$28,209,882	7,562,971	0		$3.73	Q2 2025
31 Mar 2025	0.5%	0%	$20,873,800	7,562,971	0		$2.76	Q1 2025
31 Dec 2024	0.87%	0%	$41,898,859	7,562,971	0		$5.54	Q4 2024
30 Sep 2024	1.2%	-0.01%	$63,075,178	7,562,971	-56,164	-0.74%	$8.34	Q3 2024
30 Jun 2024	1.1%	0%	$51,886,309	7,619,135	0		$6.81	Q2 2024
31 Mar 2024	0.99%	0%	$49,981,526	7,619,135	0		$6.56	Q1 2024
31 Dec 2023	0.99%	0%	$49,448,186	7,619,135	0		$6.49	Q4 2023
30 Sep 2023	0.89%	0%	$38,324,249	7,619,135	0		$5.03	Q3 2023
30 Jun 2023	1.3%	0%	$66,667,431	7,619,135	0		$8.75	Q2 2023
31 Mar 2023	1.8%	0%	$90,210,558	7,619,135	0		$11.84	Q1 2023
31 Dec 2022	1.6%	+0.03%	$77,562,794	7,619,135	+137,931	+1.8%	$10.18	Q4 2022
30 Sep 2022	0.9%	+0.44%	$44,064,000	7,481,204	+3,690,000	+97%	$5.89	Q3 2022
30 Jun 2022	0.19%	0%	$9,402,000	3,791,204	0		$2.48	Q2 2022
31 Mar 2022	0.18%	0%	$11,260,000	3,791,204	0		$2.97	Q1 2022
31 Dec 2021	0.35%	0%	$26,804,000	3,791,204	0		$7.07	Q4 2021
30 Sep 2021	0.45%	0%	$39,504,000	3,791,204	0		$10.42	Q3 2021
30 Jun 2021	0.48%	0%	$46,480,000	3,791,204	0		$12.26	Q2 2021
31 Mar 2021	0.82%	+0.82%	$83,406,000	3,791,204	+3,791,204	NEW	$22.00	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.